chartexchange

REVB
Revelation Biosciences, Inc. Common Stock
stockNASDAQ

At CloseOct 30, 2026 12:47:24 PM EDT
3.79USD+1.067%(+0.04)22,215
After-hoursOct 30, 2026 4:57:30 PM EDT
3.9239USD+3.533%(+0.1339)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$3.75
Beta
2.89
52-Week High
$5.80 2026-01-23
52-Week Low
$0.47 2026-10-16
SMA 50
$1.46
SMA 200
$1.32
Avg. Vol 10D
33,508
Avg. Vol 30D
58,989
Avg. Vol 90D
45,041
Relative Vol
0.38
569,059
435,199
85.8600%
5,450
Nov 5, 2026 (5d)
Jan 28, 2026 · 1-for-4 (reverse)
REVB Profile

we develop immunologic therapeutics and diagnostics designed to make the world a healthier place

REVB Performance
PeriodPriceDateChangeBeta
1W3.792026-10-23+4.24%-3.501
1M0.802026-10-01+393.20%27.242
3M0.952026-07-31+315.84%10.883
6M1.122026-05-01+252.72%4.299
1Y5.002025-10-31-20.99%2.891
2Y163.782024-10-31-97.59%—
5Y1,715,616.002022-01-11-100.00%1.317
REVB Stock Summary

Revelation Biosciences, Inc. Common Stock (NASDAQ:REVB) stock price today is $3.95, and today's volume is 22,215. REVB is up 5.347% today. The 30 day average volume is 58,989. REVB market cap is $2.25M with 569,059 shares outstanding.